MPM BioVentures 2014, L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 119 shares at $29.99 ($4K) on 2021-04-09, disclosed to the SEC on 2021-04-13.
Scheduled sale ($4k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| HOWL | SELL | 2025-11-12 | $438K | — | Filing → |